U.S – Neogen Corporation has released an enhanced version of its Veratox platform for Peanut allergen test, which optimizes sensitivity and flexibility across sample types while maintaining the rapid time-to-result and simple testing procedure standards set by the Veratox product line.
Neogen’s new Veratox Improvement Platform (Veratox VIP) for Peanut assay rapidly quantifies low levels of peanut protein residues in food products, ingredients, and clean-in-place rinses.
“As the demand for plant-based foods continues to increase, we have seen peanut proteins being processed in more new and creative ways than ever before. However, peanut remains one of the highest-priority allergens in the food industry.
“It was very important that we offer a solution that gives producers confidence as they navigate this changing landscape. The new Veratox VIP for Peanut assay is very sensitive and able to detect low levels of peanut protein while remaining fast and easy to use,” said John Adent, Neogen’s President and CEO.
This innovative quantitative test utilizes the pairing of a unique antibody combination and a modified extraction process to robustly detect levels of peanut protein down to 0.25 parts per million (ppm).
This product has been validated in a wide variety of product types, including both minimally and further-processed products. According to Neogen, this flexibility makes the assay appropriate across different food manufacturing and laboratory environments.
Neogen Corporation develops and markets products and services dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, ruminant by-products, drug residues, plant diseases and sanitation concerns.
Neogen is a recognized leader in the development and marketing of diagnostic tests to detect the inadvertent contamination of food with allergens that are not listed on the ingredient label.
As such, it has an extensive line of rapid test kits for over 19 different food allergens, including peanut, milk, egg, almond, gliadin (gluten), soy, mustard and hazelnut.
According to The Insight Partners’ research, the global food allergen testing market was valued at US$ 592.39 million in 2018 and is likely to hit US$ 1,198.53 million by 2027, rising at a stellar annual growth rate of 8.2 % from 2019 to 2027.
The rising prevalence of food allergies and stringent food allergen labeling compliances are the critical factors credited for market expansion.